Skip to main content
. 2017 Nov 15;8(61):103283–103289. doi: 10.18632/oncotarget.22464

Table 3. The correlation between anti-NY-ESO-1 positivity and the initial symptoms of intrahepatic cholangiocarcinoma.

Initial demonstration Univariate associations Multivariate associations
Crud Odd ratio P value Adjusted Odd ratio P value
Fever 1.83 (0.78–2.01) 0.45 1.06 (0.69–1.43) 0.68
Abdominal pain 4.53 (1.29–8.31) <0.001 2.66 (1.10–4.47) 0.04
Nausea 1.99 (0.61–1.56) 0.26 0.95 (0.48–1.22) 0.57
Emesis 1.29 (0.81–3.27) 0.24 0.66 (0.79–2.04) 0.62
Jaundice/pruritus 1.28 (1.30–4.23) 0.02 0.97 (0.80–3.19) 0.39
Anorexia 1.58 (0.34–5.89) 0.43 1.02 (0.46–3.37) 0.55
Asymptomatic 1.05 (0.64–5.73) 0.72 0.89 (0.48–4.41) 0.84